喘中的三重额外精细固定剂量组合:从随机对照试验到现实世界的证据
Paola Rogliani1, Gian Marco Manzetti1, Ilaria De Guido1
1Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome "Tor Vergata", Rome, Italy.
Expert opinion on drug delivery
|July 1, 2025
概括
三重额外细微固剂组合疗法通过向小呼吸道功能障碍,有效治疗喘. 结合随机对照试验 (RCT) 和现实世界的证据 (RWE) 证实了它的好处,尽管需要进一步的研究.
科学领域:
- 肺部医学 肺部医学
- 药理学 药理学是指药理学的学科.
- 呼吸道疾病 呼吸道疾病
背景情况:
- 小呼吸道功能障碍影响50-90%的喘患者,导致呼吸道重塑和降低生活质量.
- 吸入的超细配方 (<2μm) 对于向小呼吸道功能障碍至关重要.
- 使用吸入性皮质类固醇 (ICS),长效β2-激动剂 (LABA) 和长效肌抗体 (LAMA) 的三重疗法已被批准用于不受控制的喘.
研究的目的:
- 评估三重额外精细固剂组合治疗在喘中的影响.
- 整合随机对照试验 (RCT) 和现实世界的证据 (RWE) 的发现.
主要方法:
- 这篇叙述性综述综合了已发表的RCT (TRIMARAN,TRIGGER) 和RWE的数据.
- 还考虑了RCT的后期分析和初步的灰色文献.
主要成果:
- RCT和RWE在三重额外精细固剂组合治疗的结果中显示出显著的重叠.
- 在RCT和RWE之间注意到患者特征的差异,例如吸烟状态.
- 在患有持续空气流量限制的患者中,三重额外精细固定剂量组合可能更有效.
结论:
- 三重额外细微固剂组合疗法在RCT和RWE中显示出一致的疗效.
- 需要进一步的研究来解决剩余的知识差距,包括最佳剂量和与其他治疗策略的比较.
- 通过额外精细配方准小呼吸道功能障碍是喘管理的关键策略.
相关概念视频
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
01:26COPD: Management Using Bronchodilators and Corticosteroids
324
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
324
01:23Inhaled Medications
407
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
407
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
476
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
476
01:19Antiasthma Drugs: Leukotriene Modifiers
495
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
495
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
399
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
399